| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 0 | 682 | 1,145 | 1,224 | 1,292 | 1,285 | 1,170 | 1,306 | 1,160 | 1,139 | 1,077 | 1,020 | 969 | 1,070 | 1,020 | 1,040 | 1,056 | 1,047 | 1,041 |
| Expenses | 0 | 580 | 863 | 1,027 | 1,074 | 1,153 | 1,025 | 1,151 | 1,007 | 1,043 | 959 | 902 | 871 | 983 | 915 | 921 | 919 | 905 | 896 |
| EBITDA | 0 | 102 | 281 | 197 | 219 | 132 | 145 | 156 | 153 | 96 | 119 | 118 | 98 | 87 | 105 | 119 | 137 | 142 | 145 |
| Operating Profit % | 0 % | 15 % | 24 % | 16 % | 16 % | 10 % | 12 % | 11 % | 13 % | 8 % | 10 % | 11 % | 9 % | 7 % | 9 % | 11 % | 12 % | 13 % | 13 % |
| Depreciation | 0 | 22 | 32 | 31 | 30 | 31 | 31 | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 |
| Interest | 0 | 7 | 13 | 7 | 5 | 6 | 4 | 5 | 7 | 6 | 12 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 |
| Profit Before Tax | 0 | 77 | 243 | 165 | 187 | 115 | 116 | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 |
| Tax | 0 | 23 | 75 | 54 | 58 | 46 | 36 | 40 | 30 | 23 | 24 | 22 | 17 | 22 | 17 | 21 | 26 | 28 | 25 |
| Net Profit | 0 | 54 | 168 | 111 | 129 | 69 | 79 | 84 | 92 | 52 | 58 | 58 | 39 | 29 | 49 | 59 | 69 | 74 | 75 |
| EPS in ₹ | 0.00 | 5.20 | 10.58 | 6.97 | 8.12 | 4.31 | 4.99 | 5.31 | 5.75 | 3.29 | 3.63 | 3.64 | 2.44 | 1.85 | 3.08 | 3.73 | 4.39 | 4.69 | 4.75 |
Jubilant Ingrevia
Jubilant Ingrevia
651.20
+2.95
(0.46%)
Key Fundamentals
Market Cap
10,372.40 Cr
EPS
15.89
PE Ratio
37.36
Dividend Yield
0.77 %
Industry
Chemicals 52 Week High
885.00
52 Week Low
535.20
PB Ratio
3.54
Debt to Equity
0.27
Sector
Specialty Chemicals Analyst Rating and Forecast
- By Refinitiv from3 analysts
Actual
Company News
View All News
Jubilant Ingrevia Redeems Rs. 50 Crore Commercial Paper on MaturitySep 25, 2025
Jubilant Ingrevia Limited has fully redeemed its Commercial Paper worth Rs. 50 crores on the maturity date of September 25, 2025. The Commercial Paper, bearing ISIN INE0BY014417, was originally issued on August 11, 2025. The company informed stock exchanges NSE and BSE about the completion of the redemption process.
Jubilant Ingrevia Sets Record Date for Rs. 50 Crore Commercial Paper MaturitySep 25, 2025
Jubilant Ingrevia Limited announced the record date for maturity of its Commercial Paper issue worth Rs. 50 crore. The CP with ISIN INE0BY014425 was issued on September 25, 2025, and will mature on November 21, 2025. The record date has been set for November 20, 2025. The commercial paper is listed on the National Stock Exchange of India.
Jubilant Ingrevia Limited issued commercial papers worth Rs. 50 crore on September 25, 2025, with a 57-day tenure and 5.95% per annum interest rate. The papers will mature on November 21, 2025, with upfront interest payment and principal repayment at maturity. The commercial papers are listed on the National Stock Exchange and are unsecured with no special rights attached. The Finance Committee had previously approved issuance of commercial papers up to Rs. 600 crore outstanding at any point in time. Following this issuance, the company's total outstanding commercial papers amount to Rs. 100 crore.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,510.60 | #1 1,53,735.90 | 69.84 | 13,387.50 | 6.91 | #1 2,096 | 18.69 | 51.49 | |
3,024.50 | 89,653.70 | 62.63 | 14,825.80 | 12.13 | 1,251 | 71.41 | 64.00 | |
3,728.00 | 40,952.10 | 65.77 | 4,853.20 | 10.61 | 546 | 70.37 | 54.50 | |
1,789.30 | 24,404.80 | 40.19 | 8,365.80 | 7.84 | 697 | -44.54 | 43.63 | |
4,741.10 | 24,277.20 | 68.48 | 2,393.10 | 12.83 | 289 | #1 128.91 | 51.99 | |
4,591.50 | 19,874.60 | 50.97 | #1 15,339.40 | 10.81 | 479 | -37.72 | 47.22 | |
1,721.70 | 17,848.10 | 41.78 | 2,292.50 | 18.24 | 405 | 23.75 | 50.59 | |
6,032.00 | 17,759.30 | 35.49 | 5,692.40 | #1 18.99 | 499 | 18.11 | 37.35 | |
4,658.20 | 14,282.00 | #1 34.92 | 2,366.70 | 7.83 | 411 | 3.35 | 46.31 | |
378.00 | 13,706.00 | 58.34 | 7,285.40 | 14.16 | 331 | -68.61 | 43.60 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
1.06 %
Net Income Growth
37.34 %
Cash Flow Change
18.17 %
ROE
28.44 %
ROCE
18.41 %
EBITDA Margin (Avg.)
20.75 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 |
| Current Assets | 0 | 1,424 | 1,765 | 1,818 | 1,780 | 1,853 |
| Capital Work in Progress | 0 | 65 | 174 | 525 | 331 | 525 |
| Investments | 0 | 50 | 6 | 8 | 16 | 37 |
| Other Assets | 0 | 1,458 | 1,819 | 1,880 | 1,846 | 1,889 |
| Total Liabilities | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Current Liabilities | 0 | 894 | 1,053 | 1,180 | 1,286 | 1,401 |
| Non Current Liabilities | 0 | 561 | 311 | 413 | 708 | 704 |
| Total Equity | -0 | 1,923 | 2,433 | 2,666 | 2,738 | 2,927 |
| Reserve & Surplus | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 |
| Share Capital | 0 | 16 | 16 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 73 | -36 | 35 | 6 | -9 |
| Investing Activities | 0 | 33 | -71 | -469 | -568 | -389 |
| Operating Activities | 0 | 112 | 453 | 463 | 430 | 508 |
| Financing Activities | 0 | -72 | -418 | 42 | 144 | -129 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 50.68 % | 50.92 % | 50.92 % | 51.03 % | 51.10 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 45.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.35 % | 6.58 % | 6.55 % | 7.22 % | 6.89 % | 7.12 % | 6.96 % |
| DIIs | 0.83 % | 0.96 % | 0.32 % | 0.14 % | 0.15 % | 0.17 % | 1.38 % | 4.90 % | 5.98 % | 6.73 % | 8.21 % | 11.18 % | 13.61 % | 14.09 % | 15.47 % | 15.99 % | 15.92 % | 21.80 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.76 % | 21.30 % | 27.18 % | 26.23 % | 27.31 % | 27.61 % | 26.71 % | 25.75 % | 25.72 % | 26.13 % | 24.11 % | 22.74 % | 20.63 % | 20.57 % | 19.47 % | 19.17 % | 19.13 % | 19.41 % |
| Others | 31.74 % | 26.82 % | 21.58 % | 22.60 % | 21.43 % | 20.75 % | 20.44 % | 17.87 % | 16.83 % | 15.66 % | 16.20 % | 8.26 % | 7.71 % | 7.32 % | 6.36 % | 6.47 % | 6.36 % | 6.60 % |
| No of Share Holders | 60,038 | 95,235 | 1,49,939 | 1,81,847 | 1,91,477 | 1,93,858 | 1,95,704 | 1,86,895 | 1,85,062 | 1,86,294 | 1,73,533 | 1,62,202 | 1,50,388 | 1,42,736 | 1,25,367 | 1,24,830 | 1,20,406 | 1,23,748 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 5 | 5 | 5 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 1.39 | 1.1 | 0.77 | 0.77 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Feb 2021 |  Change Of Name | NA | 01 Feb 2021 | 0.00 | 0.00 |
| 06 Aug 2021 |  Dividend | ₹ 0.35 /share | 05 Aug 2021 | 571.85 | 610.15 |
| 11 Feb 2022 | Dividend | ₹ 2.50 /share | 10 Feb 2022 | 572.25 | 567.85 |
| 24 Aug 2022 | Dividend | ₹ 2.50 /share | 23 Aug 2022 | 464.15 | 476.15 |
| 10 Feb 2023 | Dividend | ₹ 2.50 /share | 10 Feb 2023 | 472.90 | 472.65 |
| 10 Aug 2023 | Dividend | ₹ 2.50 /share | 10 Aug 2023 | 422.00 | 433.05 |
| 09 Feb 2024 | Dividend | ₹ 2.50 /share | 09 Feb 2024 | 460.65 | 436.55 |
| 02 Aug 2024 | Dividend | ₹ 2.50 /share | 02 Aug 2024 | 519.65 | 612.55 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 610.10 | 642.85 |
| 22 Oct 2024 |  Quarterly Result Announcement | NA | 22 Oct 2024 | 732.20 | 731.40 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 711.10 | 659.30 |
| 03 Feb 2025 | Dividend | ₹ 2.50 /share | 03 Feb 2025 | 659.30 | 697.65 |
| 13 May 2025 | Quarterly Result Announcement | NA | 13 May 2025 | 696.10 | 718.00 |
| 25 Jul 2025 | Dividend | ₹ 2.50 /share | 25 Jul 2025 | 718.00 | 819.20 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 818.85 | 810.60 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 754.40 | 727.55 |
Announcements
Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended September 30 2025
2 days ago
2 days agoSubmission Of Communication Email Sent To Shareholders Whose Dividend(S) Remains Unpaid Pursuant To "Saksham Niveshak - 100 Days Campaign"2 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
4 days agoClosure of Trading WindowOct 01, 2025
Oct 01, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 25, 2025
Sep 25, 2025Intimation of Repayment of Commercial Paper (CP)Sep 25, 2025
Sep 25, 2025Intimation Of Record Date For Maturity Of Commercial PaperSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesSep 22, 2025
Sep 22, 2025Intimation Of Record Date For Maturity Of Commercial PaperSep 22, 2025
Sep 22, 2025Intimation of Repayment of Commercial Paper (CP)Sep 16, 2025
Sep 16, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 16, 2025
Sep 16, 2025Intimation of Repayment of Commercial Paper (CP)Sep 15, 2025
Sep 15, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 15, 2025
Sep 15, 2025Appointment And Re-Appointment Of Directors Statutory Auditors And Secretarial AuditorsAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 29, 2025
Aug 29, 2025Appointment And Re-Appointment Of Directors Statutory Auditors And Secretarial AuditorsAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 19, 2025
Aug 19, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 19, 2025
Aug 19, 2025Intimation Of Record Date For Maturity Of Commercial PapersAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesAug 11, 2025
Aug 11, 2025E-Mail To Shareholders Intimating About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2024-25Aug 07, 2025
Aug 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Transcript Of The Investors Conference
Call For The Quarter Ended June 30 2025Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Aug 06, 2025Intimation Regarding Letter Dispatched To The Shareholders Of The Company For Annual Report Of The Company For FY 2024-25Aug 06, 2025
Aug 06, 2025Notice Of 6Th Annual General Meeting Along With Annual Report For The Financial Year 2024-25Aug 05, 2025
Aug 05, 2025Reg. 34 (1) Annual Report.Aug 05, 2025
Aug 05, 2025Notice Of 6Th Annual General Meeting Along With The Annual Report For The Financial Year 2024-25Aug 05, 2025
Aug 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2025
Aug 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025
Aug 01, 2025Audio Recording Of Investors Conference CallJul 31, 2025
Jul 31, 2025Redemption Of Commercial PapersJul 31, 2025
Jul 31, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Grant Of Stock OptionsJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 31, 2025
Jul 31, 2025Unaudited Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2025Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 23, 2025
Jul 23, 2025Board Meeting Intimation for The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025Jul 23, 2025
Jul 23, 2025Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended June 30 2025Jul 23, 2025
Jul 23, 2025Mutual Fund Holdings
Bandhan Small Cap Fund Direct-Growth 
HDFC Manufacturing Fund Direct - Growth 
Kotak Small Cap Fund Direct-Growth 
UTI Small Cap Fund Direct - Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Groww Nifty Smallcap 250 Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 38.27
ATR(14)
Less Volatile 19.58
STOCH(9,6)
Neutral 57.87
STOCH RSI(14)
Neutral 78.21
MACD(12,26)
Bullish 0.47
ADX(14)
Strong Trend 27.42
UO(9)
Bearish 48.89
ROC(12)
Downtrend And Accelerating -3.09
WillR(14)
Neutral -63.76
About Jubilant Ingrevia
Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider. Incorporated in 2019, the company serves Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers. It operates through three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The company manufactures and supplies speciality intermediates, nutrition & health solutions, and life science chemicals through five facilities in India. Jubilant Ingrevia is the global largest producer of Niacinamide and among the top two manufacturers of Vitamin B3 globally. It serves over 1400 customers in more than 60 countries and offers custom research and manufacturing services. The company is part of the Jubilant Bhartia Group and became a separate entity following a demerger from Jubilant Pharmova Limited in 2021.
Chairperson NameShyam S Bhartia
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
